Publications Andreas Birkenfeld
Oquendo, M.B. ; Lorza-Gil, E. ; Gerst, F. ; Fend, F. ; Koenigsrainer, A. ; Wagner, R. ; Heni, M. ; Häring, H.-U. ; Birkenfeld, A.L. ; Ullrich, S. ; Siegel-Axel, D.
Comparison between in vitro differentiation of pancreatic and subcutaneous adipocytes of subjects with normal glucose tolerance.Hummel, J. ; Benkendorff, C. ; Vosseler, A. ; Fritsche, L. ; Kullmann, S. ; Birkenfeld, A.L. ; Preissl, H. ; Häring, H.-U. ; Fritsche, A. ; Peter, A. ; Wagner, R. ; Heni, M.
Brain insulin sensitivity is modulated by menstrual cycle.Wagner, L. ; Kullmann, S. ; Veit, R. ; Schneeweiss, P. ; Niess, A. ; Preissl, H. ; Birkenfeld, A.L. ; Peter, A. ; Häring, H.-U. ; Böhm, A. ; Weigert, C. ; Heni, M.
Exercise changes neuronal processing of food cues in sedentary overweight and obese adults.Vosseler, A. ; Fritsche, L. ; Hummel, J. ; Dannecker, C. ; Stefan, N. ; Birkenfeld, A.L. ; Häring, H.-U. ; Fritsche, A. ; Wagner, R. ; Heni, M.
Postprandial thermogenesis is reduced in obesity.Aberle, J. ; Menzen, M. ; Schmid, S.M. ; Terkamp, C. ; Jaeckel, E. ; Rohwedder, K. ; Scheerer, M.F. ; Xu, J. ; Tang, W. ; Birkenfeld, A.L.
Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes.Randrianarisoa, E. ; Lehn-Stefan, A. ; Hieronimus, A. ; Wagner, R. ; Maucher, J. ; Rittig, K. ; Balletshofer, B. ; Birkenfeld, A.L. ; Peter, A. ; Stefan, N. ; Häring, H.-U. ; Fritsche, A. ; Heni, M.
Reduced insulin clearance is linked to subclinical atherosclerosis in individuals at risk for type 2 diabetes mellitus.Schork, A. ; Bohnert, B.N. ; Heyne, N. ; Birkenfeld, A.L. ; Artunc, F.
Overhydration measured by bioimpedance spectroscopy and urinary serine protease activity are risk factors for progression of chronic kidney disease.Vosseler, A. ; Zhao, D. ; Fritsche, L. ; Lehmann, R. ; Kantartzis, K. ; Small, D.M. ; Peter, A. ; Häring, H.-U. ; Birkenfeld, A.L. ; Fritsche, A. ; Wagner, R. ; Preissl, H. ; Kullmann, S. ; Heni, M.
No modulation of postprandial metabolism by transcutaneous auricular vagus nerve stimulation: A cross-over study in 15 healthy men.Frankó, A. ; Berti, L. ; Hennenlotter, J. ; Rausch, S. ; Scharpf, M.O. ; Hrabě de Angelis, M. ; Stenzl, A. ; Peter, A. ; Birkenfeld, A.L. ; Lutz, S.Z. ; Häring, H.-U. ; Heni, M.
Increased expressions of matrix metalloproteinases (MMPs) in prostate cancer tissues of men with type 2 diabetes.Schütt, K. ; Forst, T. ; Birkenfeld, A.L. ; Zirlik, A. ; Müller-Wieland, D. ; Marx, N.
Diabetes mellitus and heart.Parhofer, K.G. ; Birkenfeld, A.L. ; Krone, W. ; Lehrke, M. ; Marx, N. ; Merkel, M. ; Schütt, K.S. ; Zirlik, A. ; Müller-Wieland, D.
Lipidtherapie bei Patienten mit Diabetes mellitus – Eine gemeinsame Stellungnahme der Kommission Fettstoffwechsel sowie der AG Herz und Diabetes der Deutschen Diabetes Gesellschaft (DDG), der Sektion Diabetologie und Stoffwechsel der Deutschen Gesellschaft für Endokrinologie (DGE), der AG Herz und Diabetes der Deutschen Gesellschaft für Kardiologie (DGK) und der gemeinsamen AG Herz – Hormone – Diabetes der DGK, DGE und DDG.Kullmann, S. ; Abbas, Z. ; Machann, J. ; Scheffler, K. ; Birkenfeld, A.L. ; Häring, H.-U. ; Fritsche, A. ; Heni, M.
Investigating obesity-associated brain inflammation using quantitative water content mapping.Lorza-Gil, E. ; Kaiser, G. ; Rexen Ulven, E. ; König, G.M. ; Gerst, F. ; Oquendo, M.B. ; Birkenfeld, A.L. ; Häring, H.-U. ; Kostenis, E. ; Ulven, T. ; Ullrich, S.
FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: A comparative study with mouse islets and rat INS-1E cells.Schleger, F. ; Fritsche, L. ; Birkenfeld, A.L. ; Heni, M. ; Fritsche, A.
Materner Metabolismus und fetale Entwicklung.Wali, J.A. ; Koay, Y.C. ; Chami, J. ; Wood, C. ; Corcilius, L. ; Payne, R.J. ; Rodionov, R.N. ; Birkenfeld, A.L. ; Samocha-Bonet, D. ; Simpson, S.J. ; O'Sullivan, J.F.
Nutritional and metabolic regulation of the metabolite dimethylguanidino valeric acid: An early marker of cardiometabolic disease.Hoffmann, C. ; Schneeweiss, P. ; Randrianarisoa, E. ; Schnauder, G. ; Kappler, L. ; Machann, J. ; Schick, F. ; Fritsche, A. ; Heni, M. ; Birkenfeld, A.L. ; Niess, A.M. ; Häring, H.-U. ; Weigert, C. ; Moller, A.
Response of mitochondrial respiration in adipose tissue and muscle to 8 weeks of endurance exercise in obese subjects.Frankó, A. ; Berti, L. ; Guirguis, A. ; Hennenlotter, J. ; Wagner, R. ; Scharpf, M.O. ; Hrabě de Angelis, M. ; Wissmiller, K. ; Lickert, H. ; Stenzl, A. ; Birkenfeld, A.L. ; Peter, A. ; Häring, H.-U. ; Lutz, S.Z. ; Heni, M.
Characterization of hormone-dependent pathways in six human prostate-cancer cell lines: A gene-expression study.Soldo, J. ; Heni, M. ; Königsrainer, A. ; Häring, H.-U. ; Birkenfeld, A.L. ; Peter, A.
Increased hepatic ACE2 expression in NAFL and diabetes-A risk for COVID-19 patients?Henke, C. ; Töllner, K. ; van Dijk, R.M. ; Miljanovic, N. ; Cordes, T. ; Twele, F. ; Bröer, S. ; Ziesak, V. ; Rohde, M. ; Hauck, S.M. ; Vogel, C. ; Welzel, L. ; Schumann, T. ; Willmes, D.M. ; Kurzbach, A. ; El-Agroudy, N.N. ; Bornstein, S.R. ; Schneider, S.A. ; Jordan, J. ; Potschka, H. ; Metallo, C.M. ; Köhling, R. ; Birkenfeld, A.L. ; Löscher, W.
Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus.Mathieu, C. ; Dandona, P. ; Birkenfeld, A.L. ; Krarup Hansen, T. ; Iqbal, N. ; Xu, J. ; Repetto, E. ; Scheerer, M.F. ; Thorén, F. ; Phillip, M.
Benefit/risk profile of dapagliflozin 5 mg in theDEPICT-1 and-2 trials in individuals with type 1 diabetes and body mass index >= 27 kg/m(2).Machann, J. ; Stefan, N. ; Wagner, R. ; Fritsche, A. ; Bell, J.D. ; Whitcher, B. ; Häring, H.U. ; Birkenfeld, A.L. ; Nikolaou, K. ; Schick, F. ; Thomas, E.L.
Normalized indices derived from visceral adipose mass assessed by magnetic resonance imaging and their correlation with markers for insulin resistance and prediabetes.Frankó, A. ; Berti, L. ; Hennenlotter, J. ; Rausch, S. ; Scharpf, M.O. ; Hrabě de Angelis, M. ; Stenzl, A. ; Birkenfeld, A.L. ; Peter, A. ; Lutz, S.Z. ; Häring, H.-U. ; Heni, M.
Transcript levels of aldo-keto reductase family 1 subfamily C (AKR1C) are increased in prostate tissue of patients with type 2 diabetes.Frankó, A. ; Shao, Y. ; Heni, M. ; Hennenlotter, J. ; Hoene, M. ; Hu, C. ; Liu, X. ; Zhao, X. ; Wang, Q. ; Birkenfeld, A.L. ; Todenhöfer, T. ; Stenzl, A. ; Peter, A. ; Häring, H.-U. ; Lehmann, R. ; Xu, G. ; Lutz, S.Z.
Human prostate cancer is characterized by an increase in urea cycle metabolites.Preissl, H. ; Peter, A. ; Häring, H.-U. ; Wagner, R. ; Eckstein, S.S. ; Birkenfeld, A.L. ; Hummel, J. ; Fritsche, A. ; Fritsche, L. ; Heni, M. ; Winzenried, M.
GLP-1 hypersecretion in gestational diabetes.Wagner, R. ; Stefan, N. ; Schick, F. ; Preissl, H. ; Machann, J. ; Heni, M. ; Häring, H.-U. ; Fritsche, A. ; Birkenfeld, A.L. ; Reichert, S. ; Dietz, B. ; Schwab, P. ; Dienes, J.K. ; Bauer, S. ; Schölkopf, B.
Detection of diabetes from whole-body magnetic resonance imaging using deep learning.Xiao, M. ; Bohnert, B.N. ; Aypek, H. ; Kretz, O. ; Grahammer, F. ; Aukschun, U. ; Wörn, M. ; Janessa, A. ; Essigke, D. ; Daniel, C. ; Amann, K. ; Huber, T.B. ; Plow, E.F. ; Birkenfeld, A.L. ; Artunc, F.
Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome.Bornstein, S.R. ; Rubino, F. ; Khunti, K. ; Mingrone, G. ; Hopkins, D. ; Birkenfeld, A.L. ; Boehm, B. ; Amiel, S. ; Holt, R.I. ; Skyler, J.S. ; deVries, J.H. ; Renard, E. ; Eckel, R.H. ; Zimmet, P. ; Alberti, K.G. ; Vidal, J. ; Geloneze, B. ; Ludwig, B.
Practical recommendations for the management of diabetes in patients with COVID-19.Stefan, N. ; Birkenfeld, A.L. ; Schulze, M.B. ; Ludwig, D.S.
Obesity and impaired metabolic health in patients with COVID-19.Tofte, N. ; Lindhardt, M. ; Adamova, K. ; Bakker, S.J.L. ; Beige, J. ; Beulens, J.W.J. ; Birkenfeld, A.L. ; Currie, G. ; Delles, C. ; Dimos, I. ; Francová, L. ; Frimodt-Møller, M. ; Girman, P. ; Göke, R. ; Havrdova, T. ; Heerspink, H.J.L. ; Kooy, A. ; Laverman, G.D. ; Mischak, H. ; Navis, G. ; Nijpels, G. ; Noutsou, M. ; Ortiz, A. ; Parvanova, A. ; Persson, F. ; Petrie, J.R. ; Ruggenenti, P.L. ; Rutters, F. ; Rychlík, I. ; Siwy, J. ; Spasovski, G. ; Speeckaert, M. ; Trillini, M. ; Zürbig, P. ; von der Leyen, H. ; Rossing, P. ; PRIORITY investigators
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): A prospective observational study and embedded randomised placebo-controlled trial.Garvey, W.T. ; Birkenfeld, A.L. ; Dicker, D. ; Mingrone, G. ; Pedersen, S.D. ; Satylganova, A. ; Skovgaard, D. ; Sugimoto, D. ; Jensen, C. ; Mosenzon, O.
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial.Angelini, G. ; Gissey, L.C. ; Del Corpo, G. ; Giordano, C. ; Cerbelli, B. ; Severino, A. ; Manco, M. ; Basso, N. ; Birkenfeld, A.L. ; Bornstein, S.R. ; Genco, A. ; Mingrone, G. ; Casella, G.
Publisher Correction: New insight into the mechanisms of ectopic fat deposition improvement after bariatric surgery (Scientific reports (2019) 9 1 (17315)).Schumann, T. ; König, J. ; Henke, C. ; Willmes, D.M. ; Bornstein, S.R. ; Jordan, J. ; Fromm, M.F. ; Birkenfeld, A.L.
Solute carrier transporters as potential targets for the treatment of metabolic disease.Capristo, E. ; Panunzi, S. ; De Gaetano, A. ; Raffaelli, M. ; Guidone, C. ; Iaconelli, A. ; L'Abbate, L. ; Birkenfeld, A.L. ; Bellantone, R. ; Bornstein, S. ; Mingrone, G.
Intensive lifestyle modifications with or without liraglutide 3 mg vs. sleeve gastrectomy: A three-arm non-randomised, controlled, pilot study (vol 44, pg 235, 2018).